Frequent coauthors
- JOHNSON PATRICK S 34
- RYCKMANS THOMAS 34
- STOBIE ALAN 34
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…